Last Updated 5 March 2021.
2 Vaccines Approved for Use in Peru
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 68 countries
12 trials in 9 countries
-
Sinopharm (Beijing)
BBIBP-CorV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 19 countries
6 trials in 7 countries
5 Vaccines in Clinical Trials in Peru
-
Curevac
CVnCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 4 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 other countries
8 trials in 17 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 68 other countries
22 trials in 13 countries
-
Sinopharm (Beijing)
BBIBP-CorV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 19 countries
6 trials in 7 countries
-
Sinopharm (Wuhan)
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 other countries
6 trials in 7 countries